BCMU
VIVS

BlueCrest Capital Management (UK)’s VivoSim Labs VIVS Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-43
Closed -$79K – 735
2014
Q1 		$79K Buy
+43
New +$99.9K ﹤0.01% 492

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CNB
City National Bank Beverly Hills, California $11.6B AUM 3.11% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

BlueCrest Capital Management (UK)'s VIVS Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of VivoSim Labs (VIVS) in Q2 2014, closing a stake of 43 shares — an estimated $79K sold.

BlueCrest Capital Management (UK) first reported a position in VIVS in Q1 2014 and held it in 1 quarter. The position peaked at $79K in Q1 2014. 115 funds tracked by Wall St. Rank hold VIVS as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining VivoSim Labs position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 43 VivoSim Labs shares in Q2 2014, an estimated $79K.
  • BlueCrest Capital Management (UK) first reported a position in VivoSim Labs in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s VivoSim Labs position peaked at $79K in Q1 2014.
  • 115 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.